Упрощенная HTML-версия
184
51.
Crusius J. B. Cytokine gene polymorphisms and the risk of
adenocarcinoma of the stomach in the European prospective investigation into
cancer and nutrition (EPIC-EURGAST) / J. B. Crusius [et al.] // Annals of
oncology : official journal of the European Society for Medical Oncology. –
2008. – Vol. 19, № 11. – P. 1894-1902.
52.
de Vries A.C. Biopsy strategies for endoscopic surveillance of pre-
malignant gastric lesions / A.C. de Vries [et al.] // Helicobacter. – 2010. –
Vol. 15, № 4. – P. 259-264.
53.
de Vries A.C. Gastric cancer risk in patients with premalignant gastric
lesions: a nationwide cohort study in the Netherlands / A.C. de Vries [et al.] //
Gastroenterology. – 2008. – Vol. 134, № 4. – P. 945-952.
54.
Dinarello C.A. Biologic basis for interleukin-1 in disease / C.A.
Dinarello // Blood. – 1996. – №87. – P. 2095-2147.
55.
istological classification of gastritis and Helicobacter
pylori infection: an agreement at last? The International Workshop on the
Histopathology of Gastritis / M.F.
et al.] //
– 1997. –
Vol. 2, № 1. – P.:17-24.
56.
Eaton K.A. The role of T cell subsets and cytokines in the
pathogenesis ofHelicobacter pylori gastritis in mice. / K.A. Eaton, M.
Mefford, T.Thevenot // Journal of immunology. 2001. – Vol. 166, № 12. –
P.: 7456-7461.
57.
El-Omar E. M. Interleukin-1 polymorphisms associated with
increased risk of gastric cancer/ E. M. El-Omar [et al.] // Nature. – 2000. –
Vol. 404. – P.398-402.
58.
El-Omar E.M. Increased risk of noncardia gastric cancer associated
with proinflammatory cytokine gene polymorphisms / E.M. El-Omar [et al.] //
Gastroenterology. – 2003. – Vol. 124, № 5. – P. 1193-1201.